Methylnaltrexone for Opioid-induced Constipation in Cancer Patients
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of methylnaltrexone in relieving
opioid-induced constipation in cancer patients at various stages of disease.